Hungary's Egis appoints new CFO
This article was originally published in Scrip
Executive Summary
Hungary's second-largest manufacturer of generic pharmaceuticals, Egis, has appointed Csaba Poroszlai as its new chief financial officer, effective from the end of this month. He will replace Dr Laszlo Marosffy, who is set to retire. Mr Poroszlai was most recently head of strategic controlling at Egis. He was also CFO of Beres Pharmaceuticals, another local company, from 2003-08 before he joined Egis.